New Zealand’s health regulator Medsafe has approved the paediatric Pfizer vaccine against Covid-19 for children of age 5 to 12 years, the health ministry said in a statement.

• Coal India, AMNS Sign MoU on Syn-Gas at Paradip Plant
• HAL Hits 52-Week High of Rs 5,055 on Strong Q1 Results
• MP Approves Rs 1,757 Crore Bhopal-Vidisha Road Project
• Nvidia Reportedly Developing 1 Trillion-Parameter AI Model
• West Coast Paper Hits 52-Week High on Strong Q1 Profit

The temporary approval is for two doses of the paediatric Pfizer Covid-19 vaccine, which can be given in at least 21 days break, the statement said. If the cabinet approves the vaccine, the paediatric Pfizer vaccine will be started in New Zealand by the end of January 2022, the health ministry added.